ESG

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

A 41-year-old mother's massive heart attack on Valentine's Day sparked a miraculous story of survival, advanced medicine, and profound gratitude.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

Customers face a 3% interim water rate hike in January as regulators review a plan that could see bills climb over 30% to fund infrastructure.

The Emberly at Heritage Glen opens, combining advanced AI care monitoring with a people-first philosophy to meet Fort Worth’s growing senior care needs.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

As Northern Trust prepares its Q4 2025 earnings call, investors seek clues on its resilience amid shifting economic tides and strategic digital pivots.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

XA Investments is launching a new index for credit interval funds, a move set to demystify a booming but opaque market for investors and asset managers.

SBA head Kelly Loeffler gives her 2025 pay to charity, a move that mixes disaster relief with support for controversial political group Turning Point USA.

New York's Peripherii launches Priamble™, audio earrings blending luxury jewelry with open-ear tech. Is this the future of wearable sound for women?

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

Oncodesign Precision Medicine and Navigo Proteins end their radiotheranostics pact, shifting focus to internal programs amid high-stakes R&D challenges.

Drawing from his own journey, the veteran journalist establishes a national scholarship to empower students who have turned adversity into purpose.

A new multiyear pact between Envision Healthcare and BCBS of Arizona ends uncertainty, ensuring stable in-network access to critical medical services.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

The Danish firm scraps its 2025 revenue forecast, accepting a larger loss in a bold move to secure more lucrative future deals for its key drug candidates.

Arizona State University just crossed $1 billion in research spending. This is the story of its disruptive rise and what it means for health, defense, and AI.